Bill Text: IA HF543 | 2017-2018 | 87th General Assembly | Introduced
NOTE: There are more recent revisions of this legislation. Read Latest Draft
Bill Title: A bill for an act relating to child in need of assistance and child abuse cases involving certain drugs and other substances. (Formerly HF 276.) Effective 7-1-17.
Spectrum: Committee Bill
Status: (Passed) 2017-04-20 - Signed by Governor. H.J. 1115. [HF543 Detail]
Download: Iowa-2017-HF543-Introduced.html
Bill Title: A bill for an act relating to child in need of assistance and child abuse cases involving certain drugs and other substances. (Formerly HF 276.) Effective 7-1-17.
Spectrum: Committee Bill
Status: (Passed) 2017-04-20 - Signed by Governor. H.J. 1115. [HF543 Detail]
Download: Iowa-2017-HF543-Introduced.html
House File 543 - Introduced HOUSE FILE BY COMMITTEE ON HUMAN RESOURCES (SUCCESSOR TO HF 276) A BILL FOR 1 An Act relating to child in need of assistance and child abuse 2 cases involving certain drugs and other substances. 3 BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF IOWA: TLSB 2018HV (2) 87 rh/rj PAG LIN 1 1 Section 1. Section 232.2, subsection 6, paragraph p, Code 1 2 2017, is amended to read as follows: 1 3 p. Whose parent, guardian,orcustodian, or other adult 1 4 member of the household in which a child resides does any 1 5 of the following: unlawfully uses, possesses, manufactures, 1 6 cultivates, or distributes a dangerous substance in the 1 7 presence of a child,; or knowingly allows such use, possession, 1 8 manufacture, cultivation, or distribution by another person 1 9 in the presence of a child,;or in the presence of a child1 10 possesses a productcontaining ephedrine, its salts, optical 1 11 isomers, salts of optical isomers, or pseudoephedrine, its 1 12 salts, optical isomers, salts of optical isomers,with the 1 13 intent to use the product as a precursor or an intermediary to 1 14 a dangerous substance in the presence of a child; or unlawfully 1 15 uses, possesses, manufactures, cultivates, or distributes a 1 16 dangerous substance specified in subparagraph (2), subparagraph 1 17 division (a), (b), or (c), in a child's home, on the premises, 1 18 or in a motor vehicle located on the premises. 1 19 (1) For the purposes of this paragraph, "in the presence 1 20 of a child" means in the physical presence of a childduring 1 21 the manufacture or possession, the manufacture or possession 1 22 occurred in a child's home, on the premises, or in a motor 1 23 vehicle located on the premises, or the manufacture or 1 24 possession occurredor occurring under other circumstances 1 25 in which a reasonably prudent person would know that the 1 26 use, possession, manufactureor possession, cultivation, or 1 27 distribution may be seen, smelled, ingested, or heard by a 1 28 child. 1 29 (2) For the purposes of this paragraph, "dangerous 1 30 substance" means any of the following: 1 31 (a) Amphetamine, its salts, isomers, or salts of its 1 32 isomers. 1 33 (b) Methamphetamine, its salts, isomers, or salts of its 1 34 isomers. 1 35 (c) A chemical or combination of chemicals that poses a 2 1 reasonable risk of causing an explosion, fire, or other danger 2 2 to the life or health of persons who are in the vicinity while 2 3 the chemical or combination of chemicals is used or is intended 2 4 to be used in any of the following: 2 5 (i) The process of manufacturing an illegal or controlled 2 6 substance. 2 7 (ii) As a precursor in the manufacturing of an illegal or 2 8 controlled substance. 2 9 (iii) As an intermediary in the manufacturing of an illegal 2 10 or controlled substance. 2 11 (d) Cocaine, its salts, isomers, salts of its isomers, or 2 12 derivatives. 2 13 (e) Heroin, its salts, isomers, salts of its isomers, or 2 14 derivatives. 2 15 (f) Opium and opiate, and any salt, compound, derivative, or 2 16 preparation of opium or opiate. 2 17 Sec. 2. Section 232.68, subsection 2, paragraph a, 2 18 subparagraph (7), Code 2017, is amended to read as follows: 2 19 (7) The person responsible for the care of a childhas, 2 20 in the presence ofthea child, as defined in section 232.2, 2 21 subsection 6, paragraph "p",manufacturedunlawfully uses, 2 22 possesses, manufactures, cultivates, or distributes a dangerous 2 23 substance, as defined in section 232.2, subsection 6, paragraph 2 24 "p", orin the presence of the childknowingly allows such 2 25 use, possession, manufacture, cultivation, or distribution 2 26 by another person in the presence of a child; possesses a 2 27 productcontaining ephedrine, its salts, optical isomers, salts 2 28 of optical isomers, or pseudoephedrine, its salts, optical 2 29 isomers, salts of optical isomers,with the intent to use 2 30 the product as a precursor or an intermediary to a dangerous 2 31 substance in the presence of a child; or unlawfully uses, 2 32 possesses, manufactures, cultivates, or distributes a dangerous 2 33 substance specified in section 232.2, subsection 6, paragraph 2 34 "p", subparagraph (2), subparagraph division (a), (b), or (c), 2 35 in a child's home, on the premises, or in a motor vehicle 3 1 located on the premises. 3 2 Sec. 3. Section 232.77, subsection 2, Code 2017, is amended 3 3 to read as follows: 3 4 2. a. If a health practitioner discovers in a child 3 5 physical or behavioral symptoms of the effects of exposure 3 6 to cocaine, heroin, amphetamine, methamphetamine, or other 3 7 illegal drugs, or combinations or derivatives thereof, which 3 8 were not prescribed by a health practitioner, or if the health 3 9 practitioner has determined through examination of the natural 3 10 mother of the child that the child was exposed in utero, the 3 11 health practitioner may perform or cause to be performed a 3 12 medically relevant test, as defined in section 232.73, on the 3 13 child. The practitioner shall report any positive results of 3 14 such a test on the child to the department. The department 3 15 shall begin an assessment pursuant to section 232.71B upon 3 16 receipt of such a report. A positive test result obtained 3 17 prior to the birth of a child shall not be used for the criminal 3 18 prosecution of a parent for acts and omissions resulting in 3 19 intrauterine exposure of the child to an illegal drug. 3 20 b. If a health practitioner involved in the delivery or 3 21 care of a newborn or infant discovers in the newborn or infant 3 22 physical or behavioral symptoms that are consistent with the 3 23 effects of prenatal drug exposure or a fetal alcohol spectrum 3 24 disorder, the health practitioner shall report such information 3 25 to the department in a manner prescribed by rule of the 3 26 department. 3 27 EXPLANATION 3 28 The inclusion of this explanation does not constitute agreement with 3 29 the explanation's substance by the members of the general assembly. 3 30 This bill relates to certain drugs and other substances and 3 31 child in need of assistance and child abuse cases. 3 32 The bill amends the definition of a child in need of 3 33 assistance to provide that an unmarried child whose parent, 3 34 guardian, custodian, or other adult member of the child's 3 35 household unlawfully uses, possesses, manufactures, cultivates, 4 1 or distributes a dangerous substance in the presence of a child 4 2 or knowingly allows such activities by another person in the 4 3 presence of a child; possesses a product with the intent to use 4 4 the product as a precursor or an intermediary to a dangerous 4 5 substance in the presence of a child; or unlawfully uses, 4 6 possesses, manufactures, cultivates, or distributes a dangerous 4 7 substance that is an amphetamine, a methamphetamine, or a 4 8 chemical or chemicals that pose a reasonable risk of causing a 4 9 fire or explosion in a child's home, on the premises, or in a 4 10 motor vehicle located on the premises, may be the subject of a 4 11 child in need of assistance petition. 4 12 The bill amends the definition of child abuse to provide that 4 13 a person responsible for the care of a child who unlawfully 4 14 uses, possesses, manufactures, cultivates, or distributes a 4 15 dangerous substance in the presence of a child or knowingly 4 16 allows such activities by another person in the presence of a 4 17 child; possesses a product with the intent to use the product 4 18 as a precursor or an intermediary to a dangerous substance 4 19 in the presence of a child; or unlawfully uses, possesses, 4 20 manufactures, cultivates, or distributes a dangerous substance 4 21 that is an amphetamine, a methamphetamine, or a chemical or 4 22 chemicals that pose a reasonable risk of causing a fire or 4 23 explosion in a child's home, on the premises, or in a motor 4 24 vehicle located on the premises may be the subject of an 4 25 allegation of child abuse. 4 26 The bill amends the definitions of "in the presence of a 4 27 child" and "dangerous substance" for purposes of both child 4 28 in need of assistance and child abuse definitions. "In 4 29 the presence of a child" means in the physical presence of 4 30 a child or occurring under other circumstances in which a 4 31 reasonably prudent person would know that the use, possession, 4 32 manufacture, cultivation, or distribution may be seen, 4 33 smelled, ingested, or heard by a child. The bill includes 4 34 cocaine, heroin, and opium or opiates in the list of dangerous 4 35 substances. 5 1 The bill requires a health practitioner involved in the 5 2 delivery or care of a newborn or infant, who discovers in the 5 3 newborn or infant physical or behavioral symptoms that are 5 4 consistent with the effects of prenatal drug exposure or a 5 5 fetal alcohol spectrum disorder, to report such information 5 6 to the department of human services in a manner prescribed by 5 7 rule of the department. "Health practitioner" is defined in 5 8 Code section 232.2 to mean a licensed physician or surgeon, 5 9 osteopathic physician or surgeon, dentist, optometrist, 5 10 podiatric physician, or chiropractor, a resident or intern 5 11 of any such profession, and any registered nurse or licensed 5 12 practical nurse. This reporting requirement is required under 5 13 the federal Child Abuse Prevention and Treatment Act (CAPTA). LSB 2018HV (2) 87 rh/rj